Zobrazeno 1 - 9
of 9
pro vyhledávání: '"A. S. Kanin"'
Publikováno v:
Современная онкология, Vol 18, Iss 3, Pp 59-64 (2016)
Objectives. To evaluate therapy results of advanced-stag Hodgkin lymphoma (HL) in Kraev Oncology Centre, Khabarovsk district. Methods. The study included 76 patients with Hodgkin's lymphoma. They were observed in the Regional Oncology Centre in Khaba
Externí odkaz:
https://doaj.org/article/7faa1935a4484fe994f38d8bfae94e95
Publikováno v:
Современная онкология, Vol 18, Iss 3, Pp 59-64 (2016)
Objectives. To evaluate therapy results of advanced-stag Hodgkin lymphoma (HL) in Kraev Oncology Centre, Khabarovsk district. Methods. The study included 76 patients with Hodgkin's lymphoma. They were observed in the Regional Oncology Centre in Khaba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b48e771eea1ecb67b3a46e7677065169
https://doi.org/10.26442/1815-1434_2016.3.59-64
https://doi.org/10.26442/1815-1434_2016.3.59-64
Autor:
Eugene E. Zvonkov, Vera V. Troitskaya, Nelly G. Gabeeva, Andrey V. Gubkin, Olga A. Gavrilina, Anna Sidirova, Hunan Julhakyan, Dariya Koroleva, Elena N. Parovichnikova, Mikhail Drokov, Valerii Lapin, Vitalii S. Kanin, Valerii G. Savchenko
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:S280-S281
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6d46ae2e3f02c9b4007198413495fd3
https://doi.org/10.1016/j.clml.2018.07.212
https://doi.org/10.1016/j.clml.2018.07.212
Autor:
A. O. Koptyukhov, V. A. Lyamkin, O Y Samodurov, V. A. Ilatovskiy, A. P. Serebrov, D. V. Prudnikov, A. S. Kanin, A. T. Oprev, A. K. Fomin
Publikováno v:
KnE Energy. 3:129
The WWR-M reactor at PNPI is going to be equipped with an ultacold neutron source of high density. Method of UCN production is based on their accumulation in the super fluid helium due to particular qualities of that quantum liquid. The possibility o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a572bbe486cec073b7438bdef014223
https://doi.org/10.18502/ken.v3i1.1734
https://doi.org/10.18502/ken.v3i1.1734
Autor:
L. S. Kanin, A. A. Polinov, A. V. Chevychelov, R. S. Takhautdinov, S. A. Zakharov, M. F. Gibadullin, V. M. Parshakov, Yu. A. Bodyaev
Publikováno v:
Steel in Translation. 39:886-889
Uncooled multipoint thermal probes are used to monitor the radial gas distribution in blast furnaces with nonconical charging systems at OAO MMK. In each furnace two probes are placed at fixed locations above the charge. Such probes have been install
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f294344bc359f70f9f4a9327bb2d146
https://doi.org/10.3103/s0967091209100106
https://doi.org/10.3103/s0967091209100106
Publikováno v:
Journal of Physics: Conference Series. 798:012147
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48a802d7a30b3c009b7489bb929c28d0
https://doi.org/10.1088/1742-6596/798/1/012147
https://doi.org/10.1088/1742-6596/798/1/012147
Autor:
Vera V. Troitskaya, Eugene E. Zvonkov, Vitalii S. Kanin, V A Lapin, Andrey V. Gubkin, Inessa Yu. Toropova, Olga A. Gavrilina, Elena N. Parovichnikova, Valery G. Savchenko, Nelly G. Gabeeva
Publikováno v:
Blood. 128:5386-5386
Background: The number of elderly patients with diffuse large B-cell lymphoma (DLBCL) in our aging society continues to rise. Median of age for patients with diffuse large B-cell lymphoma (DLBCL) is 60. Approximately 50% of older patients with DLBCL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79b180f7b765853880b65c77ad9b8878
https://doi.org/10.1182/blood.v128.22.5386.5386
https://doi.org/10.1182/blood.v128.22.5386.5386
Autor:
Eugene E. Zvonkov, V A Lapin, Andrey V. Gubkin, Valeri G. Savchenko, Vera V. Troitskaya, Larisa A. Kuzmina, Vitalii S. Kanin, Inessa Yu. Toropova, Elena N. Parovichnikova, Nelly G. Gabeeva, Olga A. Gavrilina
Publikováno v:
Blood. 126:2708-2708
Background: Approximately 50% of diffuse large B-cell lymphomas (DLBCL) are defined as high-grade by IPI. They are characterized by aggressive course and poor response to standard chemotherapy (CT): 5-years overall survival (OS) rate of less than 30%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ba75abe55f5eda4f62f3138f13047b3
https://doi.org/10.1182/blood.v126.23.2708.2708
https://doi.org/10.1182/blood.v126.23.2708.2708
Publikováno v:
Journal of Physics: Conference Series; 2017, Vol. 798 Issue 1, p1-1, 1p